Wnt/β-catenin signaling pathway inhibits the proliferation and apoptosis of U87 glioma cells via different mechanisms

被引:67
作者
Gao, Liyang [1 ,2 ]
Chen, Bing [3 ]
Li, Jinhong [3 ]
Yang, Fan [3 ]
Cen, Xuecheng [3 ]
Liao, Zhuangbing [3 ]
Long, Xiao'ao [3 ]
机构
[1] Ningxia Univ, Sch Life Sci, Yinchuan, Peoples R China
[2] Guangdong Med Univ, Affiliated Hosptial, Stem Cell Res & Cellular Therapy Ctr, Zhanjiang, Peoples R China
[3] Guangdong Med Univ, Affiliated Hosp, Dept Neurosurg, Zhanjiang, Peoples R China
关键词
BETA-CATENIN; WNT; EXPRESSION; GROWTH; INVASION; TARGET; ANGIOGENESIS; FIBRONECTIN; LAMININ; MARKER;
D O I
10.1371/journal.pone.0181346
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Wnt signaling pathway is necessary for the development of the central nervous system and is associated with tumorigenesis in various cancers. However, the mechanism of the Wnt signaling pathway in glioma cells has yet to be elucidated. Small-molecule Wnt modulators such as ICG-001 and AZD2858 were used to inhibit and stimulate the Wnt/beta-catenin signaling pathway. Techniques including cell proliferation assay, colony formation assay, Matrigel cell invasion assay, cell cycle assay and Genechip microarray were used. Gene Ontology Enrichment Analysis and Gene Set Enrichment Analysis have enriched many biological processes and signaling pathways. Both the inhibiting and stimulating Wnt/beta-catenin signaling pathways could influence the cell cycle, moreover, reduce the proliferation and survival of U87 glioma cells. However, Affymetrix expression microarray indicated that biological processes and networks of signaling pathways between stimulating and inhibiting the Wnt/beta-catenin signaling pathway largely differ. We propose that Wnt/beta-catenin signaling pathway might prove to be a valuable therapeutic target for glioma.
引用
收藏
页数:19
相关论文
共 50 条
[1]   RETRACTED: Origin of the U87MG glioma cell line: Good news and bad news (Retracted article. See vol. 19, 2024) [J].
Allen, Marie ;
Bjerke, Mia ;
Edlund, Hanna ;
Nelander, Sven ;
Westermark, Bengt .
SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (354)
[2]   Stem cell signaling as a target for novel drug discovery: recent progress in the WNT and Hedgehog pathways [J].
An, Songzhu Michael ;
Ding, Qiang Peter ;
Li, Ling-song .
ACTA PHARMACOLOGICA SINICA, 2013, 34 (06) :777-783
[3]   Analysis of Oct4-dependent transcriptional networks regulating self-renewal and pluripotency in human embryonic stem cells [J].
Babaie, Yasmin ;
Herwig, Ralf ;
Greber, Boris ;
Brink, Thore C. ;
Wruck, Wasco ;
Groth, Detlef ;
Lehrach, Hans ;
Burdon, Tom ;
Adjaye, James .
STEM CELLS, 2007, 25 (02) :500-510
[4]   Estrogen receptor a enhances the transcriptional activity of ETS-1 and promotes the proliferation, migration and invasion of neuroblastoma cell in a ligand dependent manner [J].
Cao, Peng ;
Feng, Fan ;
Dong, Guofu ;
Yu, Chunyong ;
Feng, Sizhe ;
Song, Erlin ;
Shi, Guobing ;
Liang, Yong ;
Liang, Guobiao .
BMC CANCER, 2015, 15
[5]   Glioma Cell Proliferation Controlled by ERK Activity-Dependent Surface Expression of PDGFRA [J].
Chen, Dongfeng ;
Zuo, Duo ;
Luan, Cheng ;
Liu, Min ;
Na, Manli ;
Ran, Liang ;
Sun, Yingyu ;
Persson, Annette ;
Englund, Elisabet ;
Salford, Leif G. ;
Renstrom, Erik ;
Fan, Xiaolong ;
Zhang, Enming .
PLOS ONE, 2014, 9 (01)
[6]   HOXA13 is a potential GBM diagnostic marker and promotes glioma invasion by activating the Wnt and TGF-β pathways [J].
Duan, Ran ;
Han, Lei ;
Wang, Qixue ;
Wei, Jianwei ;
Chen, Luyue ;
Zhang, Jianning ;
Kang, Chunsheng ;
Wang, Lei .
ONCOTARGET, 2015, 6 (29) :27778-27793
[7]   A small molecule inhibitor of β-catenin/cyclic AMP response element-binding protein transcription [J].
Emami, KH ;
Nguyen, C ;
Ma, H ;
Kim, DH ;
Jeong, KW ;
Eguchi, M ;
Moon, RT ;
Teo, JL ;
Oh, SW ;
Kim, HY ;
Moon, SH ;
Ha, JR ;
Kahn, M .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (34) :12682-12687
[8]   Neurofibromatosis 2 [Bilateral acoustic neurofibromatosis, central neurofibromatosis, NF2, neurofibromatosis type II] [J].
Evans, D. Gareth R. .
GENETICS IN MEDICINE, 2009, 11 (09) :599-610
[9]   Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma [J].
Fenstermaker, Robert A. ;
Ciesielski, Michael J. ;
Qiu, Jingxin ;
Yang, Nuo ;
Frank, Cheryl L. ;
Lee, Kelvin P. ;
Mechtler, Laszlo R. ;
Belal, Ahmed ;
Ahluwalia, Manmeet S. ;
Hutson, Alan D. .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2016, 65 (11) :1339-1352
[10]  
Gao J, 2015, INT J CLIN EXP PATHO, V8, P10130